Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • EXTRAORDINARY GENERAL MEETING 27 SEPTEMBER 2022
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November 2020
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Rights issue 2022
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • Analyst
  • IR Contact
  • Presentations

Nomination committee

In accordance with the decision at Qlife Holding's Annual General Meeting 2022, the company's Chairman of the Board has convened a Nomination Committee to prepare proposals for the Company's Annual General Meeting 2023.

The Nomination Committee consists of the following persons, who together represent approximately 24 percent of the company's shares and votes.

  • Anita Otterheim Hjalmarsson, appointed by Thomas Warthoe,
  • John Moll, appointed by Lars Bangsgaard,
  • Peter Warthoe, representing own shares,
  • Mette Gross, Chairman of the Board.

The Nomination Committee's proposal will be presented in the notice convening the Annual General Meeting 2023 and on the company's website, www.qlifeholding.com. Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the Nomination Committee at the company's address, Redaregatan 48, 252 36 Helsingborg. In order for the Nomination Committee to be able to consider a proposal, the proposal must have been received in due time before the Annual General Meeting, and no later than 6th February 2023.

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health
Last published: 2022-08-15

Links

  • About
  • Investors
  • Egoo.health

Qlife is born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on health-care into tomorrow's focus on health-empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. it's how we contribute to improving quality of life for every individual and for the greater society.